ADS-ADEA 2015* , ,
Presentations this author is a contributor to:
Effect of Empagliflozin Compared with Glimepiride as Add-on to Metformin for 2 Years on the Amount and Distribution of Body Fat in Patients with Type 2 Diabetes (T2DM) (#169)
4:45 PM
Ted Wu
ADS Clinical Orals: Therapies for Type 2 Diabetes
Contrasting Influences of Renal Function on Blood Pressure and HbA1c Reductions with Empagliflozin: Pooled Analysis of Phase III Trials (#202)
10:30 AM
Mark Cooper
ADS Clinical Orals: Kidney Function in Diabetes